CoChat

Multi-domain interventions for the prevention of dementia and cognitive decline

Open access
Hafdi, Melanie, Hoevenaar-Blom, Marieke P., Richard, Edo · 2020 · Cochrane Database of Systematic Reviews
Cited by 65

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Dementia is a worldwide concern. Its global prevalence is increasing. Currently, no effective medical treatment exists to cure or to delay the onset of cognitive decline or dementia. Up to 40% of dementia is attributable to potentially modifiable risk factors, which has led to the notion that targeting these risk factors might reduce the incidence of cognitive decline and dementia. Since sporadic dementia is a multifactorial condition, thought to derive from multiple causes and risk factors, multi-domain interventions may be more effective for the prevention of dementia than those targeting single risk factors. OBJECTIVES: To assess the effects of multi-domain interventions for the prevention of cognitive decline and dementia in older adults, including both unselected populations and populations at increased risk of cognitive decline and dementia. SEARCH METHODS: We searched ALOIS, the Cochrane Dementia and Cognitive Improvement Group's register, MEDLINE (Ovid SP), Embase (Ovid SP), PsycINFO (Ovid SP), CINAHL (EBSCOhost), Web of Science Core Collection (ISI Web of Science), LILACS (BIREME), and ClinicalTrials.gov on 28 April 2021. We also reviewed citations of reference lists of included studies, landmark papers, and review papers to identify additional studies and assessed their suitability for inclusion in the review. SELECTION CRITERIA: We defined a multi-domain intervention as an intervention with more than one component, pharmacological or non-pharmacological, but not consisting only of two or more drugs with the same therapeutic target. We included randomised controlled trials (RCTs) evaluating the effect of such an intervention on cognitive functioning and/or incident dementia. We accepted as control conditions any sham intervention or usual care, but not single-domain interventions intended to reduce dementia risk. We required studies to have a minimum of 400 participants and an intervention and follow-up duration of at least 12 months. DATA COLLECTION AND ANALYSIS: We initially screened search results using a 'crowdsourcing' method in which members of Cochrane's citizen science platform identify RCTs. We screened the identified citations against inclusion criteria by two review authors working independently. At least two review authors also independently extracted data, assessed the risk of bias and applied the GRADE approach to assess the certainty of evidence. We defined high-certainty reviews as trials with a low risk of bias across all domains other than blinding of participants and personnel involved in administering the intervention (because lifestyle interventions are difficult to blind). Critical outcomes were incident dementia, incident mild cognitive impairment (MCI), cognitive decline measured with any validated measure, and mortality. Important outcomes included adverse events (e.g. cardiovascular events), quality of life, and activities of daily living (ADL). Where appropriate, we synthesised data in random-effects meta-analyses. We expressed treatment effects as risk ratios (RRs) and mean differences (MDs) with 95% confidence intervals (CIs). MAIN RESULTS: We included nine RCTs (18.452 participants) in this review. Two studies reported incident dementia as an outcome; all nine studies reported a measure for cognitive functioning. Assessment of cognitive functioning was very heterogeneous across studies, ranging from complete neuropsychological assessments to short screening tests such as the mini-mental state examination (MMSE). The duration of the interventions varied from 12 months to 10 years. We compared multi-domain interventions against usual care or a sham intervention. Positive MDs and RRs <1 favour multi-domain interventions over control interventions. For incident dementia, there was no evidence of a difference between the multi-domain intervention group and the control group (RR 0.94, 95% CI 0.76 to 1.18; 2 studies; 7256 participants; high-certainty evidence). There was a small difference in composite Z-score for cognitive function measured with a neuropsychological test battery (NTB) (MD 0.03, 95% CI 0.01 to 0.06; 3 studies; 4617 participants; high-certainty evidence) and with the Montreal Cognitive Assessment (MoCA) scale (MD 0.76 point, 95% CI 0.05 to 1.46; 2 studies; 1554 participants), but the certainty of evidence for the MoCA was very low (due to serious risk of bias, inconsistency and indirectness) and there was no evidence of an effect on the MMSE (MD 0.02 point, 95% CI -0.06 to 0.09; 6 studies; 8697participants; moderate-certainty evidence). There was no evidence of an effect on mortality (RR 0.93, 95% CI 0.84 to 1.04; 4 studies; 11,487 participants; high-certainty evidence). There was high-certainty evidence for an interaction of the multi-domain intervention with ApoE4 status on the outcome of cognitive function measured with an NTB (carriers MD 0.14, 95% CI 0.04 to 0.25, noncarriers MD 0.04, 95% CI -0.02 to 0.10, P for interaction 0.09). There was n

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/14651858.cd013572

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 52 references

Research works printed but not linked: 23

  1. Alexopoulos, 2003, Vascular disease, depression, and dementia, Journal of the American Geriatrics Society, 51, 1178, 10.1046/j.1532-5415.2003.51373.x · DOI · Paper page
  2. Areosa Sastre, 2017, Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD003804.pub2 · DOI · Paper page
  3. Barnes, 2011, The projected effect of risk factor reduction on Alzheimer's disease prevalence, Lancet Neurology, 10, 819, 10.1016/S1474-4422(11)70072-2 · DOI · Paper page
  4. Brown, 2013, Multiple effects of physical activity on molecular and cognitive signs of brain aging: can exercise slow neurodegeneration and delay Alzheimer's disease?, Molecular Psychiatry, 18, 864, 10.1038/mp.2012.162 · DOI · Paper page
  5. Coley, 2008, Dementia prevention: methodological explanations for inconsistent results, Epidemiologic Reviews, 30, 35, 10.1093/epirev/mxn010 · DOI · Paper page
  6. Higgins JPT Thomas J Chandler J Cumpston M Li T Page MJ Welch VA (editors) Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019) Cochrane, 2019. Available from www.training.cochrane.org/handbook.The Cochrane Collaboration, 2011. Available from handbook.cochrane.org · DOI · Paper page
  7. Kessing, 2004, Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder?, Journal of Neurology, Neurosurgery, and Psychiatry, 75, 1662, 10.1136/jnnp.2003.031773 · DOI · Paper page
  8. Leckie, 2014, BDNF mediates improvements in executive function following a 1-year exercise intervention, Frontiers in Human Neuroscience, 8, 985, 10.3389/fnhum.2014.00985 · DOI · Paper page
  9. Luchsinger, 2009, Adiposity, type 2 diabetes, and Alzheimer's disease, Journal of Alzheimer's Disease, 16, 693, 10.3233/JAD-2009-1022 · DOI · Paper page
  10. McCarrey, 2015, Postmenopausal hormone therapy and cognition, Hormones and Behaviour, 74, 167, 10.1016/j.yhbeh.2015.04.018 · DOI · Paper page
  11. Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, PLoS Medicine, 6, e1000097, 10.1371/journal.pmed.1000097 · DOI · Paper page
  12. Norton, 2014, Potential for primary prevention of Alzheimer's disease: an analysis of population-based data, Lancet Neurology, 13, 788, 10.1016/S1474-4422(14)70136-X · DOI · Paper page
  13. Ott, 1999, Diabetes mellitus and the risk of dementia: the Rotterdam Study, Neurology, 53, 1937, 10.1212/WNL.53.9.1937 · DOI · Paper page
  14. Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014
  15. Richard, 2009, Prevention of dementia by intensive vascular care (PreDIVA): a cluster-randomized trial in progress, Alzheimer Disease and Associated Disorders, 23, 198, 10.1097/WAD.0b013e31819783a4 · DOI · Paper page
  16. Solomon, 2007, Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study, Neurology, 68, 751, 10.1212/01.wnl.0000256368.57375.b7 · DOI · Paper page
  17. Solomon, 2014, Advances in the prevention of Alzheimer's disease and dementia, Journal of Internal Medicine, 275, 229, 10.1111/joim.12178 · DOI · Paper page
  18. Tolppanen, 2014, Midlife and late-life body mass index and late-life dementia: results from a prospective population-based cohort, Journal of Alzheimer's Disease, 38, 201, 10.3233/JAD-130698 · DOI · Paper page
  19. Tzourio, 2014, Is hypertension associated with an accelerated aging of the brain?, Hypertension, 63, 894, 10.1161/HYPERTENSIONAHA.113.00147 · DOI
  20. Middelaar, 2018, Blood pressure-lowering interventions to prevent dementia: a systematic review and meta-analysis, Journal of Hypertension, 36, 1780, 10.1097/HJH.0000000000001829 · DOI · Paper page
  21. Vliet, 2009, The influence of age on the association between cholesterol and cognitive function, Experimental Gerontology, 44, 112, 10.1016/j.exger.2008.05.004 · DOI
  22. Winblad, 2016, Defeating Alzheimer's disease and other dementias: a priority for European science and society, Lancet Neurology, 15, 455, 10.1016/S1474-4422(16)00062-4 · DOI · Paper page
  23. Yehuda, 2002, The role of polyunsaturated fatty acids in restoring the aging neuronal membrane, Neurobiology of Aging, 23, 843, 10.1016/S0197-4580(02)00074-X · DOI · Paper page

Cited by

See all 65

Metadata

Authors
Hafdi, M., Hoevenaar-Blom, M. P., & Richard, E.
Venue
Cochrane Database of Systematic Reviews
Publisher
Wiley
Published
2020-04-02
Volume
11
Pages
CD013572-CD013572
ISSN
  • 1361-6137 (ISSN-L)
  • 1465-1858
OpenAlex
W3014841452
Cited by
65
References
52
FWCI
4.47
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Multi-domain interventions for the prevention of dementia and cognitive decline. https://app.cochat.ai/papers/10.1002/14651858.cd013572
The paper
Hafdi, M., Hoevenaar-Blom, M. P., & Richard, E. (2020). Multi-domain interventions for the prevention of dementia and cognitive decline. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd013572

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.